Do analysts prefer PAVM or NVNO?

PAVmed currently has a consensus price target of $56.00, indicating a potential upside of 2,021.21%. Given PAVmed's higher probable upside, equities analysts plainly believe PAVmed is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Is PAVM or NVNO more profitable?

enVVeno Medical has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. enVVeno Medical's return on equity of -62.28% beat PAVmed's return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -10,794.64% -126.43% -25.49% enVVeno Medical N/A -62.28% -56.83%

Do analysts recommend NVNO or HSCS?

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 158.90%. Given HeartSciences' higher probable upside, analysts plainly believe HeartSciences is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings and valuation, NVNO or HSCS?

HeartSciences is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio enVVeno Medical N/A N/A -$19.47M -$19.33 N/A HeartSciences N/A N/A -$9.14M -$3.22 N/A

Is NVNO or HSCS more profitable?

enVVeno Medical's return on equity of -62.28% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets enVVeno Medical N/A -62.28% -56.83% HeartSciences N/A -816.90% -181.97%

Do analysts prefer LFWD or NVNO?

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 63.27%. Given Lifeward's higher possible upside, research analysts clearly believe Lifeward is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Is LFWD or NVNO more profitable?

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -141.28%. enVVeno Medical's return on equity of -62.28% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -141.28% -235.86% -81.72% enVVeno Medical N/A -62.28% -56.83%

Do analysts rate NVNO or FEMY?

Femasys has a consensus target price of $50.00, suggesting a potential upside of 2,740.91%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Is NVNO or FEMY more profitable?

enVVeno Medical has a net margin of 0.00% compared to Femasys' net margin of -534.36%. enVVeno Medical's return on equity of -62.28% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets enVVeno Medical N/A -62.28% -56.83% Femasys -534.36% -225.97% -74.68%

Do analysts rate ICU or NVNO?

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 122.84%. Given SeaStar Medical's higher possible upside, analysts plainly believe SeaStar Medical is more favorable than enVVeno Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 enVVeno Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

enVVeno Medical (NVNO) Competitors

$7.40 -0.57 (-7.15%)

Closing price 04:00 PM Eastern

Extended Trading

$7.35 -0.05 (-0.68%)

As of 07:13 PM Eastern

Compare

NVNO vs. PAVM, HSCS, LFWD, FEMY, and ICU

Should you buy enVVeno Medical stock or one of its competitors? enVVeno Medical's main competitors and comparable companies include PAVmed (PAVM), HeartSciences (HSCS), Lifeward (LFWD), Femasys (FEMY), and SeaStar Medical (ICU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does enVVeno Medical compare to PAVmed?

PAVmed (NASDAQ:PAVM) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings.

19.9% of PAVmed shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 13.4% of PAVmed shares are owned by company insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

PAVmed has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

PAVmed has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$70K	301.71	$400K	-$16.05	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

In the previous week, PAVmed had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for PAVmed and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat PAVmed's score of 0.89 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
PAVmed	Positive
enVVeno Medical	Very Positive

enVVeno Medical has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. enVVeno Medical's return on equity of -62.28% beat PAVmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-10,794.64%	-126.43%	-25.49%
enVVeno Medical	N/A	-62.28%	-56.83%

PAVmed currently has a consensus price target of $56.00, indicating a potential upside of 2,021.21%. Given PAVmed's higher probable upside, equities analysts plainly believe PAVmed is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Summary

enVVeno Medical beats PAVmed on 8 of the 15 factors compared between the two stocks.

How does enVVeno Medical compare to HeartSciences?

enVVeno Medical (NASDAQ:NVNO) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

HeartSciences has a consensus price target of $8.00, indicating a potential upside of 158.90%. Given HeartSciences' higher probable upside, analysts plainly believe HeartSciences is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

enVVeno Medical has a beta of 1.29, meaning that its share price is 29% more volatile than the broader market. Comparatively, HeartSciences has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market.

enVVeno Medical's return on equity of -62.28% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-62.28%	-56.83%
HeartSciences	N/A	-816.90%	-181.97%

HeartSciences is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.22	N/A

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 4.9% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, HeartSciences had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for HeartSciences and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat HeartSciences' score of 0.73 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
HeartSciences	Positive

Summary

enVVeno Medical beats HeartSciences on 7 of the 13 factors compared between the two stocks.

How does enVVeno Medical compare to Lifeward?

Lifeward (NASDAQ:LFWD) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

In the previous week, Lifeward had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Lifeward and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat Lifeward's score of 0.61 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Lifeward	Positive
enVVeno Medical	Very Positive

enVVeno Medical has lower revenue, but higher earnings than Lifeward. enVVeno Medical is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$22.03M	0.79	-$19.91M	-$16.82	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

Lifeward has a beta of 0.47, suggesting that its share price is 53% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market.

enVVeno Medical has a net margin of 0.00% compared to Lifeward's net margin of -141.28%. enVVeno Medical's return on equity of -62.28% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-141.28%	-235.86%	-81.72%
enVVeno Medical	N/A	-62.28%	-56.83%

Lifeward currently has a consensus price target of $10.00, indicating a potential upside of 63.27%. Given Lifeward's higher possible upside, research analysts clearly believe Lifeward is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 1.1% of Lifeward shares are owned by company insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

enVVeno Medical beats Lifeward on 10 of the 15 factors compared between the two stocks.

How does enVVeno Medical compare to Femasys?

enVVeno Medical (NASDAQ:NVNO) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 7.8% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

enVVeno Medical has a net margin of 0.00% compared to Femasys' net margin of -534.36%. enVVeno Medical's return on equity of -62.28% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-62.28%	-56.83%
Femasys	-534.36%	-225.97%	-74.68%

Femasys has higher revenue and earnings than enVVeno Medical. Femasys is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A
Femasys	$2.29M	6.44	-$18.63M	-$3.53	N/A

In the previous week, Femasys had 3 more articles in the media than enVVeno Medical. MarketBeat recorded 4 mentions for Femasys and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat Femasys' score of 0.45 indicating that enVVeno Medical is being referred to more favorably in the media.

Company	Overall Sentiment
enVVeno Medical	Very Positive
Femasys	Neutral

enVVeno Medical has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market. Comparatively, Femasys has a beta of -2.16, indicating that its share price is 316% less volatile than the broader market.

Femasys has a consensus target price of $50.00, suggesting a potential upside of 2,740.91%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

enVVeno Medical and Femasys tied by winning 8 of the 16 factors compared between the two stocks.

How does enVVeno Medical compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

enVVeno Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. enVVeno Medical's return on equity of -62.28% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
enVVeno Medical	N/A	-62.28%	-56.83%

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 122.84%. Given SeaStar Medical's higher possible upside, analysts plainly believe SeaStar Medical is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

SeaStar Medical has a beta of -1.09, suggesting that its stock price is 209% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

SeaStar Medical has higher revenue and earnings than enVVeno Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	12.87	-$12.15M	-$3.91	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$19.33	N/A

In the previous week, SeaStar Medical had 5 more articles in the media than enVVeno Medical. MarketBeat recorded 6 mentions for SeaStar Medical and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.79 beat SeaStar Medical's score of 0.63 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
SeaStar Medical	Positive
enVVeno Medical	Very Positive

Summary

enVVeno Medical beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVNO vs. The Competition

Export

Metric	enVVeno Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.11M	$5.56B	$7.28B	$12.93B
Dividend Yield	N/A	1.75%	2.51%	22.89%
P/E Ratio	-0.38	25.42	275.31	25.30
Price / Sales	N/A	40.31	556.94	76.39
Price / Cash	N/A	32.25	77.16	53.04
Price / Book	0.18	5.72	10.51	5.92
Net Income	-$19.47M	$146.93M	$3.50B	$381.04M
7 Day Performance	-9.42%	-2.51%	-4.33%	-4.39%
1 Month Performance	-21.11%	-5.02%	-8.64%	-7.26%
1 Year Performance	-72.92%	0.44%	2.04%	-4.95%

enVVeno Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVNO enVVeno Medical	1.5424 of 5 stars	$7.40 -7.2%	N/A	-69.3%	$5.11M	N/A	N/A	33	Gap Down
PAVM PAVmed	2.4934 of 5 stars	$2.74 +2.6%	$56.00 +1,943.8%	-84.2%	$21.39M	$70K	N/A	41	Gap Down
HSCS HeartSciences	3.2044 of 5 stars	$3.49 -7.4%	$8.00 +129.2%	-13.7%	$18.26M	N/A	N/A	14	Gap Down
LFWD Lifeward	2.4219 of 5 stars	$6.45 +1.7%	$10.00 +55.2%	-32.0%	$17.95M	$22.03M	N/A	81	News Coverage
FEMY Femasys	3.8358 of 5 stars	$2.00 -3.8%	$50.00 +2,400.0%	-83.5%	$17.42M	$2.29M	N/A	54	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NVNO) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enVVeno Medical (NVNO) Competitors

NVNO vs. PAVM, HSCS, LFWD, FEMY, and ICU

How does enVVeno Medical compare to PAVmed?

Summary

How does enVVeno Medical compare to HeartSciences?

Summary

How does enVVeno Medical compare to Lifeward?

Summary

How does enVVeno Medical compare to Femasys?

Summary

How does enVVeno Medical compare to SeaStar Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enVVeno Medical (NVNO) Competitors

NVNO vs. PAVM, HSCS, LFWD, FEMY, and ICU

How does enVVeno Medical compare to PAVmed?

Do institutionals and insiders have more ownership in PAVM or NVNO?

Which has more volatility and risk, PAVM or NVNO?

Which has stronger valuation and earnings, PAVM or NVNO?

Does the media favor PAVM or NVNO?

Is PAVM or NVNO more profitable?

Do analysts prefer PAVM or NVNO?

Summary

How does enVVeno Medical compare to HeartSciences?

Do analysts recommend NVNO or HSCS?

Which has more risk and volatility, NVNO or HSCS?

Is NVNO or HSCS more profitable?

Which has stronger earnings and valuation, NVNO or HSCS?

Do institutionals & insiders believe in NVNO or HSCS?

Does the media prefer NVNO or HSCS?

Summary

How does enVVeno Medical compare to Lifeward?

Does the media favor LFWD or NVNO?

Which has higher valuation & earnings, LFWD or NVNO?

Which has more risk and volatility, LFWD or NVNO?

Is LFWD or NVNO more profitable?

Do analysts prefer LFWD or NVNO?

Do insiders & institutionals have more ownership in LFWD or NVNO?

Summary

How does enVVeno Medical compare to Femasys?

Do institutionals and insiders have more ownership in NVNO or FEMY?

Is NVNO or FEMY more profitable?

Which has better valuation and earnings, NVNO or FEMY?

Does the media prefer NVNO or FEMY?

Which has more volatility and risk, NVNO or FEMY?

Do analysts rate NVNO or FEMY?

Summary

How does enVVeno Medical compare to SeaStar Medical?

Do institutionals & insiders hold more shares of ICU or NVNO?

Is ICU or NVNO more profitable?

Do analysts rate ICU or NVNO?

Which has more risk & volatility, ICU or NVNO?

Which has stronger valuation & earnings, ICU or NVNO?

Does the media refer more to ICU or NVNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools